Author: Alexander Lee
Alexander Lee
Alexander is the founder and author of Microcaps.ca, a leading resource for investors interested in the micro-cap stock market. With a passion for uncovering hidden gems in the world of small-cap stocks, Alexander combines in-depth research with years of experience in the financial markets to provide readers with valuable insights and timely analysis. Investors should conduct their own research or consult with a qualified investment advisor before making any investment decisions. The author of this article is not responsible for any gains or losses incurred from investing in companies mentioned.
Xebra Brands has successfully completed the first manufacturing run of its Elements line. The authorization for importation, launch, and sale of the Elements line was granted to Elements Bioscience SAPI de C.V., a subsidiary of the company, by Mexican regulatory authorities. This milestone marks a significant advancement in Xebra Brands’ initial distribution efforts in Mexico. The Elements CBD brand, which includes capsules, tinctures, topicals, and intimate oils, positions Xebra Brands to meet the growing demand for such products in Mexico. As the only legal company authorized to domestically produce and sell CBD products in the country, Xebra Brands stands out…
Investors witnessed a week of fluctuating market activity, highlighted by anticipation of a rate cut in September. Key inflation data was awaited, with market sentiment remaining positive as major indices showed signs of recovery. The VIX index dropped significantly from the previous week, standing at 20 on Monday (August 12). Positive data surrounding the producer price index (PPI) and consumer price index (CPI) reports led to a rise in markets on subsequent days. The S&P 500 and Toronto Stock Exchange’s S&P/TSX composite index closed higher, while the Nasdaq Composite faced setbacks due to losses in specific tech stocks. With a…
In a statement by Professor Dana Rizk, an Investigator and APPLAUSE-IgAN Steering Committee Member at the University of Alabama at Birmingham Division of Nephrology, she emphasized the complex and evolving nature of IgA nephropathy, posing challenges to its effective treatment. The disease, characterized by the immune system’s attack on the kidneys, often leading to glomerular inflammation and proteinuria, affects approximately 25 individuals per million globally each year. With up to 50% of IgAN patients with persistent proteinuria progressing to kidney failure within 10 to 20 years post-diagnosis, the standard of care may not always suffice. The availability of targeted therapies…
Nextech3D.ai, a leading provider of patented 2D-3D Generative AI-Powered 3D models for major e-commerce retailers like Amazon, Miele, P&G, and Kohls, has secured a substantial order for 1,000+ 3D AI models and over 4,000+ 3D AI digital photos in May. This order, valued in the mid-six figures, underscores the company’s expertise in AI technologies and its ability to create high-quality 3D models for enterprise customers globally. CEO Evan Gappelberg highlighted the growing demand for 3D models in e-commerce and the significant return on investment they offer. By working with industry giants like Amazon and Shopify, Nextech3D.ai is at the forefront…
E3 Lithium (TSXV: ETL; US-OTC: EEMMF) is getting $5 million from the Alberta government to support its lithium brine demonstration facility as it vies to become the oil-producing province’s first producer of the battery metal. The company’s Clearwater project in Old’s, Alta. released a prefeasibility study in June reporting the first lithium brine proven mineral reserves in Canada. The investment comes through the Emissions Reduction Alberta (ERA) technology innovation and emissions reduction (TIER) fund. The project aims to help E3 Lithium achieve its goal of producing battery-grade lithium carbonate from Alberta’s brine resources. “E3 is on the path to building a new industry…
The evolving global regulatory landscape surrounding cannabis has presented a significant investment opportunity for those looking to enter this emerging market. Melodiol Global Health, a key player in the global cannabis industry, has strategically positioned itself with operations in Canada and Australia to capitalize on the changing regulations in these markets. Countries like Canada and Australia have recently implemented new laws to legalize cannabis for both medical and recreational purposes, with other regions following suit. Melodiol Global Health oversees a variety of business units that offer a range of cannabis products, including recreational and medical cannabis, hemp-based products, athletic products,…
Professor Dana Rizk, an Investigator and APPLAUSE-IgAN Steering Committee Member at the University of Alabama at Birmingham Division of Nephrology, acknowledged the challenges posed by the heterogeneous and progressive nature of IgA nephropathy. He emphasized the evolving treatment landscape for the disease, particularly highlighting the crucial role of complement activation in IgA nephropathy and the availability of targeted treatment options for patients. IgA nephropathy is a rare and progressive disease where the immune system attacks the kidneys, leading to glomerular inflammation and proteinuria. Around 25 people per million worldwide are newly diagnosed with IgA nephropathy each year. The disease progression…
During this summer season in the US, the challenge of coping with high temperatures has been compounded by the prevalence of E. coli and cyanobacteria, leading to widespread beach closures at lakes and rivers. The issue is exacerbated by the effects of climate change, which have resulted in warmer waters and more intense rainfall, creating optimal conditions for bacterial growth. The rise in water temperature of approximately 0.6F (0.3C) per decade between 1985 and 2009 has increased the risk of bacterial blooms even in historically cold areas. These bacteria can lead to various symptoms such as blisters, rashes, diarrhea, muscle…
A significant portion of Canadians, nearly 60%, contribute to a Registered Retirement Savings Plan (RRSP) on an annual basis, with an average contribution of around $3,700. The appeal of RRSP lies in its tax-deferred growth, allowing investments to grow without being taxed until withdrawal. However, despite the advantages, only about 25% of Canadians maximize their RRSP contributions each year. This lack of full utilization means missing out on potential long-term growth and tax benefits. The average RRSP balance for Canadians close to retirement (ages 55-64) is approximately $120,000, which might not be enough to support a comfortable retirement. This underscores…
The Nasdaq Composite index has shown significant growth over the past year, increasing by more than 18% fueled by a strong rally in technology stocks benefitting from factors like artificial intelligence (AI). However, the index has recently experienced a pullback. In the last month, the Nasdaq Composite index has dropped over 10% amid uncertainties in the market regarding AI’s ability to drive substantial growth for large tech companies. One such company affected by this sell-off is Alphabet, with its shares declining by 12.5% since July 23, following results that exceeded Wall Street’s expectations. Despite this downturn, this situation presents an…